IgNS 2024
Forging Better Immune Globulin Outcomes
Two new studies presented at the IgNS 2024 National Conference offer insight into treatment options for immune ...
APRIL 27, 2025
Primary Immunodeficiency Treatment and Support
An FDA-cleared immunoglobulin infusion set aims to improve the experience of people with primary immunodeficiency ...
FEBRUARY 21, 2025
Sepsis: Tips for Early Identification and Home-Based Prevention
Sepsis remains a concern for people on immunoglobulin therapy, especially those receiving infusions at home, but ...
FEBRUARY 21, 2025
Delayed Diagnoses, Suboptimal Care Cited In IgNS Patient Survey
More patients are seeking treatment for conditions that require immune globulin therapy, but delays in diagnosis ...
FEBRUARY 21, 2025
Home-Based Ig Rx Reduces Infections and Antibiotic Use
Adults with primary immunodeficiency diseases who self-administered immunoglobulin replacement therapy at home had ...
FEBRUARY 20, 2025
Basics and Benefits of Biosimilars: A Rheumatologist’s Take
The use of biosimilars can improve patient access and reduce healthcare costs, but understanding some basic ...
FEBRUARY 13, 2025
